The present invention relates to compounds of general formula (I) The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
本发明涉及一般式(I)的化合物。该化合物可用于治疗和/或预防由核受体介导的疾病,特别是
过氧化物酶体增殖物激活受体(
PPAR)。